State Street’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.48M | Buy |
1,051,967
+186,411
| +22% | +$794K | ﹤0.01% | 2991 |
|
|
2025
Q1 | $3.25M | Sell |
865,556
-991,971
| -53% | -$3.73M | ﹤0.01% | 3054 |
|
|
2024
Q4 | $10.8M | Sell |
1,857,527
-112,436
| -6% | -$656K | ﹤0.01% | 2589 |
|
|
2024
Q3 | $23.5M | Buy |
1,969,963
+21,986
| +1% | +$263K | ﹤0.01% | 2112 |
|
|
2024
Q2 | $21.1M | Sell |
1,947,977
-1,230,450
| -39% | -$13.3M | ﹤0.01% | 2143 |
|
|
2024
Q1 | $36M | Buy |
3,178,427
+2,505,257
| +372% | +$28.4M | ﹤0.01% | 1895 |
|
|
2023
Q4 | $9.44M | Buy |
673,170
+114,053
| +20% | +$1.6M | ﹤0.01% | 2630 |
|
|
2023
Q3 | $6.91M | Buy |
559,117
+63,417
| +13% | +$783K | ﹤0.01% | 2767 |
|
|
2023
Q2 | $4.48M | Buy |
495,700
+374,519
| +309% | +$3.38M | ﹤0.01% | 3041 |
|
|
2023
Q1 | $420K | Buy |
121,181
+12,100
| +11% | +$42K | ﹤0.01% | 3801 |
|
|
2022
Q4 | $267K | Buy |
109,081
+8,600
| +9% | +$21.1K | ﹤0.01% | 3991 |
|
|
2022
Q3 | $277K | Hold |
100,481
| – | – | ﹤0.01% | 3997 |
|
|
2022
Q2 | $409K | Sell |
100,481
-359,072
| -78% | -$1.46M | ﹤0.01% | 3913 |
|
|
2022
Q1 | $1.96M | Buy |
459,553
+39,522
| +9% | +$168K | ﹤0.01% | 3576 |
|
|
2021
Q4 | $3.93M | Buy |
420,031
+34,201
| +9% | +$320K | ﹤0.01% | 3353 |
|
|
2021
Q3 | $10.6M | Buy |
385,830
+181,474
| +89% | +$5M | ﹤0.01% | 2858 |
|
|
2021
Q2 | $5.72M | Buy |
204,356
+30,510
| +18% | +$854K | ﹤0.01% | 3184 |
|
|
2021
Q1 | $5.77M | Buy |
+173,846
| New | +$5.77M | ﹤0.01% | 2988 |
|